- Home
- CDNA vs SPH Comparison
CDNA vs SPH Comparison
Compare CDNA & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- SPH
- Stock Information
- Founded
- CDNA 1998
- SPH 1945
- Country
- CDNA United States
- SPH United States
- Employees
- CDNA N/A
- SPH N/A
- Industry
- CDNA Medical Specialities
- SPH Other Specialty Stores
- Sector
- CDNA Health Care
- SPH Consumer Discretionary
- Exchange
- CDNA Nasdaq
- SPH Nasdaq
- Market Cap
- CDNA 1.0B
- SPH 1.2B
- IPO Year
- CDNA 2014
- SPH 1996
- Fundamental
- Price
- CDNA $18.85
- SPH $18.20
- Analyst Decision
- CDNA Buy
- SPH Sell
- Analyst Count
- CDNA 6
- SPH 1
- Target Price
- CDNA $30.33
- SPH $17.00
- AVG Volume (30 Days)
- CDNA 959.0K
- SPH 209.3K
- Earning Date
- CDNA 07-30-2025
- SPH 08-07-2025
- Dividend Yield
- CDNA N/A
- SPH 7.16%
- EPS Growth
- CDNA N/A
- SPH N/A
- EPS
- CDNA 1.07
- SPH 1.46
- Revenue
- CDNA $346,421,000.00
- SPH $1,424,243,000.00
- Revenue This Year
- CDNA $13.31
- SPH $10.99
- Revenue Next Year
- CDNA $15.46
- SPH N/A
- P/E Ratio
- CDNA $17.58
- SPH $12.44
- Revenue Growth
- CDNA 25.92
- SPH 4.02
- 52 Week Low
- CDNA $14.09
- SPH $15.20
- 52 Week High
- CDNA $34.84
- SPH $22.24
- Technical
- Relative Strength Index (RSI)
- CDNA 51.86
- SPH 42.45
- Support Level
- CDNA $18.64
- SPH $18.00
- Resistance Level
- CDNA $19.84
- SPH $18.90
- Average True Range (ATR)
- CDNA 0.80
- SPH 0.51
- MACD
- CDNA -0.07
- SPH 0.02
- Stochastic Oscillator
- CDNA 25.60
- SPH 32.20
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.